🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

DIABASE; Diabetes Mellitus Registry in Second Care

Recruitingn/aAges 18 Years - anyAllZiekenhuisgroep Twente
NCT05584293 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study aims to examine real world data from medical devices and clinical outcome from diabetes mellitus patients to gain the necessary insights to be able to improve individual patient care by building a registry.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients with type 1 or type 2 diabetes * Patients aged 18 years or older * Patients visiting the outpatient clinic internal medicine in the ZGT Hospital * Written informed consent Exclusion Criteria: * Severe general diseases or mental disorders making the participation in the study impossible
💊

What it tests

  • Not listed
📍

Where

1 site
Ziekenhuisgroep Twente
Almelo, Netherlands
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy